Cargando…

Is intensive care beneficial for patients with haematologic malignancies?

Detalles Bibliográficos
Autores principales: Nyunga, M, Lemaire, C, Ras, E, Herbecq, P, Verheyde, I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934569/
http://dx.doi.org/10.1186/cc8655
_version_ 1782186343350140928
author Nyunga, M
Lemaire, C
Ras, E
Herbecq, P
Verheyde, I
author_facet Nyunga, M
Lemaire, C
Ras, E
Herbecq, P
Verheyde, I
author_sort Nyunga, M
collection PubMed
description
format Text
id pubmed-2934569
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29345692010-09-08 Is intensive care beneficial for patients with haematologic malignancies? Nyunga, M Lemaire, C Ras, E Herbecq, P Verheyde, I Crit Care Poster Presentation BioMed Central 2010 2010-03-01 /pmc/articles/PMC2934569/ http://dx.doi.org/10.1186/cc8655 Text en Copyright ©2010 BioMed Central Ltd.
spellingShingle Poster Presentation
Nyunga, M
Lemaire, C
Ras, E
Herbecq, P
Verheyde, I
Is intensive care beneficial for patients with haematologic malignancies?
title Is intensive care beneficial for patients with haematologic malignancies?
title_full Is intensive care beneficial for patients with haematologic malignancies?
title_fullStr Is intensive care beneficial for patients with haematologic malignancies?
title_full_unstemmed Is intensive care beneficial for patients with haematologic malignancies?
title_short Is intensive care beneficial for patients with haematologic malignancies?
title_sort is intensive care beneficial for patients with haematologic malignancies?
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934569/
http://dx.doi.org/10.1186/cc8655
work_keys_str_mv AT nyungam isintensivecarebeneficialforpatientswithhaematologicmalignancies
AT lemairec isintensivecarebeneficialforpatientswithhaematologicmalignancies
AT rase isintensivecarebeneficialforpatientswithhaematologicmalignancies
AT herbecqp isintensivecarebeneficialforpatientswithhaematologicmalignancies
AT verheydei isintensivecarebeneficialforpatientswithhaematologicmalignancies